Literature DB >> 20145131

Regulation of p53 family member isoform DeltaNp63alpha by the nuclear factor-kappaB targeting kinase IkappaB kinase beta.

Aditi Chatterjee1, Xiaofei Chang, Tanusree Sen, Rajani Ravi, Atul Bedi, David Sidransky.   

Abstract

The p53 family gene p63 plays an instrumental role in cellular stress responses including responses to DNA damage. In addition to encoding a full-length transcriptional activator, p63 also encodes several dominant inhibitory isoforms including the isoform DeltaNp63alpha, the function of which is not fully understood. DeltaNp63alpha is degraded in response to DNA damage, thereby enabling an effective cellular response to genotoxic agents. Here, we identify a key molecular mechanism underlying regulation of DeltaNp63alpha expression in response to chemotherapeutic agents or tumor necrosis factor-alpha. We found that DeltaNp63alpha interacts with IkappaB kinase (IKK), a multisubunit protein kinase that consists of two catalytic subunits, IKKalpha and IKKbeta, and a regulatory subunit, IKKgamma. The IKKbeta kinase promotes ubiquitin-mediated proteasomal degradation of DeltaNp63alpha, whereas a kinase-deficient mutant IKKbeta-K44A fails to do so. Cytokine- or chemotherapy-induced stimulation of IKKbeta caused degradation of DeltaNp63alpha and augmented transactivation of p53 family-induced genes involved in the cellular response to DNA damage. Conversely, IKKbeta inhibition attenuated cytokine- or chemotherapy-induced degradation of DeltaNp63alpha. Our findings show that IKKbeta plays an essential role in regulating DeltaNp63alpha in response to extrinsic stimuli. IKK activation represents one mechanism by which levels of DeltaNp63alpha can be reduced, thereby rendering cells susceptible to cell death in the face of cellular stress or DNA damage.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20145131      PMCID: PMC2963198          DOI: 10.1158/0008-5472.CAN-09-2613

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  41 in total

Review 1.  p63.

Authors:  Natalie A Little; Aart G Jochemsen
Journal:  Int J Biochem Cell Biol       Date:  2002-01       Impact factor: 5.085

2.  The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways.

Authors:  Emmanuel Dejardin; Nathalie M Droin; Mireille Delhase; Elvira Haas; Yixue Cao; Constantin Makris; Zhi-Wei Li; Michael Karin; Carl F Ware; Douglas R Green
Journal:  Immunity       Date:  2002-10       Impact factor: 31.745

3.  p63 expression is associated with p53 loss in oral-esophageal epithelia of p53-deficient mice.

Authors:  Y Suliman; O G Opitz; A Avadhani; T C Burns; W El-Deiry; D T Wong; A K Rustgi
Journal:  Cancer Res       Date:  2001-09-01       Impact factor: 12.701

Review 4.  NF-kappaB in cancer--a friend turned foe.

Authors:  Rajani Ravi; Atul Bedi
Journal:  Drug Resist Updat       Date:  2004-02       Impact factor: 18.500

5.  Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.

Authors:  Genevieve A Andrews; Sichuan Xi; Rebecca G Pomerantz; Charles J Lin; William E Gooding; Abbey L Wentzel; Li Wu; David Sidransky; Jennifer Rubin Grandis
Journal:  Head Neck       Date:  2004-10       Impact factor: 3.147

Review 6.  Family feud in chemosensitvity: p73 and mutant p53.

Authors:  Meredith S Irwin
Journal:  Cell Cycle       Date:  2004-03-01       Impact factor: 4.534

7.  DeltaNp63 induces beta-catenin nuclear accumulation and signaling.

Authors:  Meera Patturajan; Shuji Nomoto; Matthias Sommer; Alexey Fomenkov; Kenji Hibi; Rachel Zangen; Nina Poliak; Joseph Califano; Barry Trink; Edward Ratovitski; David Sidransky
Journal:  Cancer Cell       Date:  2002-05       Impact factor: 31.743

8.  Significance of p63 amplification and overexpression in lung cancer development and prognosis.

Authors:  Pierre P Massion; Peter M Taflan; S M Jamshedur Rahman; Pinar Yildiz; Yu Shyr; Mary E Edgerton; Matthew D Westfall; John R Roberts; Jennifer A Pietenpol; David P Carbone; Adriana L Gonzalez
Journal:  Cancer Res       Date:  2003-11-01       Impact factor: 12.701

Review 9.  How the nucleolar sequestration of p53 protein or its interplayers contributes to its (re)-activation.

Authors:  Józefa Wsierska-Gadek; Marcel Horky
Journal:  Ann N Y Acad Sci       Date:  2003-12       Impact factor: 5.691

Review 10.  Drug discovery and the p53 family.

Authors:  Constantinos Demonacos; Nicholas B La Thangue
Journal:  Prog Cell Cycle Res       Date:  2003
View more
  24 in total

1.  TNF-α promotes c-REL/ΔNp63α interaction and TAp73 dissociation from key genes that mediate growth arrest and apoptosis in head and neck cancer.

Authors:  Hai Lu; Xinping Yang; Praveen Duggal; Clint T Allen; Bin Yan; Jonah Cohen; Liesl Nottingham; Rose-Anne Romano; Satrajit Sinha; Kathryn E King; Wendy C Weinberg; Zhong Chen; Carter Van Waes
Journal:  Cancer Res       Date:  2011-09-20       Impact factor: 12.701

2.  Regulation of ΔNp63α by NFκΒ.

Authors:  Tanusree Sen; Xiaofei Chang; David Sidransky; Aditi Chatterjee
Journal:  Cell Cycle       Date:  2010-12-15       Impact factor: 4.534

3.  ΔNp63 versatilely regulates a Broad NF-κB gene program and promotes squamous epithelial proliferation, migration, and inflammation.

Authors:  Xinping Yang; Hai Lu; Bin Yan; Rose-Anne Romano; Yansong Bian; Jay Friedman; Praveen Duggal; Clint Allen; Ryan Chuang; Reza Ehsanian; Han Si; Satrajit Sinha; Carter Van Waes; Zhong Chen
Journal:  Cancer Res       Date:  2011-05-15       Impact factor: 12.701

4.  IKK phosphorylation of NF-κB at serine 536 contributes to acquired cisplatin resistance in head and neck squamous cell cancer.

Authors:  Zhipeng Li; Zejia Yang; Rena G Lapidus; Xuefeng Liu; Kevin J Cullen; Han C Dan
Journal:  Am J Cancer Res       Date:  2015-09-15       Impact factor: 6.166

5.  DeltaNp63alpha confers tumor cell resistance to cisplatin through the AKT1 transcriptional regulation.

Authors:  Tanusree Sen; Nilkantha Sen; Mariana Brait; Shahnaz Begum; Aditi Chatterjee; Mohammad Obaidul Hoque; Edward Ratovitski; David Sidransky
Journal:  Cancer Res       Date:  2011-01-25       Impact factor: 12.701

6.  Tumor protein p63/nuclear factor κB feedback loop in regulation of cell death.

Authors:  Tanusree Sen; Nilkantha Sen; Yiping Huang; Debasish Sinha; Zhen-Ge Luo; Edward A Ratovitski; David Sidransky
Journal:  J Biol Chem       Date:  2011-10-20       Impact factor: 5.157

7.  Global tumor protein p53/p63 interactome: making a case for cisplatin chemoresistance.

Authors:  Yiping Huang; Jun Seop Jeong; Jun Okamura; Myoung Sook-Kim; Heng Zhu; Rafael Guerrero-Preston; Edward A Ratovitski
Journal:  Cell Cycle       Date:  2012-06-15       Impact factor: 4.534

8.  Role of p63 in Development, Tumorigenesis and Cancer Progression.

Authors:  Johann Bergholz; Zhi-Xiong Xiao
Journal:  Cancer Microenviron       Date:  2012-07-31

Review 9.  p63-related signaling at a glance.

Authors:  Matthew L Fisher; Seamus Balinth; Alea A Mills
Journal:  J Cell Sci       Date:  2020-09-11       Impact factor: 5.285

Review 10.  Caught in the cross fire: p53 in inflammation.

Authors:  Tomer Cooks; Curtis C Harris; Moshe Oren
Journal:  Carcinogenesis       Date:  2014-06-18       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.